Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells

Haematologica. 2000 Jan;85(1):25-30.

Abstract

Background and objective: Thrombopoietin (TPO), the ligand for the c-mpl receptor, regulates in vivo platelet production and increases the number of colony-forming unit megakaryocytes (CFU-MK). Other cytokines including interleukin (IL) -3, IL-6, IL-11 and stem cell factor (SCF) can stimulate megakaryopoiesis. The aim of this study was to evaluate the effects of different combinations of cytokines involved in megakaryocytopoiesis on stroma-free liquid cultures of purified human CD34+ cells.

Design and methods: Peripheral blood cells were collected after mobilization with granulocyte colony-stimulating factor (G-CSF). Purified CD34+ cells were then cultured with different combinations of TPO, SCF, IL-3, IL-6 and IL-11.

Results: The addition of TPO and SCF alone generated a population positive for the antigens CD41 (5.5+/-2.9%) and CD61 (6. 1+/-2.2%) but induced a low amplification of cell number (8.1+/-0.9 fold expansion). The presence of IL-6 or IL-11 was associated with MK progenitor cell expansion, and up to 7-10% of cultured cells were found to be CD41 and CD61 positive by flow cytometry. Conversely, the addition of IL-3 to this cytokine combination was associated with a prominent expansion of the myeloid lineage (70+/-10% of CD33+ cells) but only 0.9% and 2% of cultured cells were positive for CD61 and CD41 respectively.

Interpretation and conclusions: Our study supports the idea that IL-6 and IL-11 play crucial roles in the proliferation of MK progenitors and the use of SCF, TPO, IL-6 and IL-11 for ex vivo expansion of this cell population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / biosynthesis
  • Antigens, CD / drug effects*
  • Antigens, CD34 / blood
  • Antigens, CD34 / drug effects
  • Antineoplastic Agents / therapeutic use
  • Blood Component Removal
  • Cell Culture Techniques
  • Cell Differentiation / drug effects
  • Cell Division / drug effects*
  • Drug Synergism
  • Humans
  • Integrin beta3
  • Interleukin-11 / pharmacology*
  • Interleukin-11 / physiology
  • Interleukin-3 / pharmacology
  • Interleukin-6 / pharmacology*
  • Interleukin-6 / physiology
  • Megakaryocytes / drug effects*
  • Megakaryocytes / immunology*
  • Platelet Glycoprotein GPIIb-IIIa Complex / biosynthesis
  • Platelet Glycoprotein GPIIb-IIIa Complex / drug effects*
  • Platelet Membrane Glycoproteins / biosynthesis
  • Platelet Membrane Glycoproteins / drug effects*
  • Stem Cell Factor / pharmacology*
  • Stem Cell Factor / physiology
  • Thrombopoietin / pharmacology*
  • Thrombopoietin / physiology
  • Transplantation Conditioning
  • Transplantation, Autologous

Substances

  • Antigens, CD
  • Antigens, CD34
  • Antineoplastic Agents
  • Integrin beta3
  • Interleukin-11
  • Interleukin-3
  • Interleukin-6
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Membrane Glycoproteins
  • Stem Cell Factor
  • Thrombopoietin